Influence of Skeletal Muscle Volume Loss During Lenvatinib Treatment on Prognosis in Unresectable Hepatocellular Carcinoma: A Multicenter Study in Tohoku, Japan
Abstract:Sarcopenia is associated with poor prognosis of patients with hepatocellular carcinoma (HCC). We investigated the association of skeletal muscle volume (SMV) and its change in HCC patients taking lenvatinib. In 132 HCC patients, psoas mass index (PMI) was calculated as the left-right sum of the vertical × horizontal diameter of psoas muscle at the third lumbar vertebra, divided by height squared. Patients were classified into two groups (low and normal PMI) based on indices of <6.0 cm2/m2 for man and <3.… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.